Lightbridge CEO Seth Grae Issues Update Letter to Shareholders
February 27, 2024 08:00 ET
|
Lightbridge Corporation
RESTON, Va., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, today issued a corporate update in a letter to...
Blockchain Startup Triall Introduces a Tokenized Ecosystem to Speed Up and Improve Medical Research
September 28, 2021 11:04 ET
|
Triall
AMSTERDAM, Sept. 28, 2021 (GLOBE NEWSWIRE) -- Blockchain startup Triall launched its main utility token TRL in an initial DEX offering (IDO) on Uniswap at 13:00 UTC today, after raising more than 2...
Trilogy International Partners Inc. Announces 2degrees 2016 Statutory Results
May 16, 2017 21:00 ET
|
Trilogy International Partners LLC
BELLEVUE, Wash., May 16, 2017 (GLOBE NEWSWIRE) -- Trilogy International Partners Inc. (the “Company”) (TSX:TRL) announced that its New Zealand subsidiary, 2degrees, achieved net income in fiscal...
Trilogy International Partners Inc. Sets Date to Report Fourth Quarter and Full Year 2016 Results
March 01, 2017 17:13 ET
|
Trilogy International Partners LLC
BELLEVUE, Wash., March 01, 2017 (GLOBE NEWSWIRE) -- Trilogy International Partners Inc. (TSX:TRL) announced today that it will report results for the fourth quarter and year ended December 31, 2016...
Hemispherx Biopharma's Ampligen(R) Cited at Barcelona Vaccine & Active Immunotherapeutics Forum 2011
May 12, 2011 13:00 ET
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, May 12, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company" or "Hemispherx") today announced that Ampligen® will be featured in a discussion of...